2-28408802-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_005253.4(FOSL2):c.398G>A(p.Arg133Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000198 in 1,612,200 control chromosomes in the GnomAD database, with no homozygous occurrence. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000021 ( 0 hom. )
Consequence
FOSL2
NM_005253.4 missense
NM_005253.4 missense
Scores
6
10
3
Clinical Significance
Conservation
PhyloP100: 9.92
Genes affected
FOSL2 (HGNC:3798): (FOS like 2, AP-1 transcription factor subunit) The Fos gene family consists of 4 members: FOS, FOSB, FOSL1, and FOSL2. These genes encode leucine zipper proteins that can dimerize with proteins of the JUN family, thereby forming the transcription factor complex AP-1. As such, the FOS proteins have been implicated as regulators of cell proliferation, differentiation, and transformation. [provided by RefSeq, Jul 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High AC in GnomAdExome4 at 31 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FOSL2 | NM_005253.4 | c.398G>A | p.Arg133Lys | missense_variant | 3/4 | ENST00000264716.9 | NP_005244.1 | |
FOSL2 | XM_006711976.4 | c.398G>A | p.Arg133Lys | missense_variant | 3/4 | XP_006712039.1 | ||
FOSL2 | XM_006711977.4 | c.281G>A | p.Arg94Lys | missense_variant | 3/4 | XP_006712040.1 | ||
FOSL2 | XM_005264231.5 | c.398G>A | p.Arg133Lys | missense_variant | 3/5 | XP_005264288.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FOSL2 | ENST00000264716.9 | c.398G>A | p.Arg133Lys | missense_variant | 3/4 | 1 | NM_005253.4 | ENSP00000264716.4 | ||
FOSL2 | ENST00000379619.5 | c.323G>A | p.Arg108Lys | missense_variant | 3/4 | 1 | ENSP00000368939.1 | |||
FOSL2 | ENST00000436647.1 | c.281G>A | p.Arg94Lys | missense_variant | 3/4 | 2 | ENSP00000396497.1 | |||
FOSL2 | ENST00000460736.1 | n.393G>A | splice_region_variant, non_coding_transcript_exon_variant | 3/3 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152258Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
1
AN:
152258
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000404 AC: 1AN: 247684Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134308
GnomAD3 exomes
AF:
AC:
1
AN:
247684
Hom.:
AF XY:
AC XY:
0
AN XY:
134308
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1459942Hom.: 0 Cov.: 30 AF XY: 0.0000124 AC XY: 9AN XY: 726218
GnomAD4 exome
AF:
AC:
31
AN:
1459942
Hom.:
Cov.:
30
AF XY:
AC XY:
9
AN XY:
726218
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152258Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74394
GnomAD4 genome
AF:
AC:
1
AN:
152258
Hom.:
Cov.:
33
AF XY:
AC XY:
0
AN XY:
74394
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
1
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 30, 2024 | The c.398G>A (p.R133K) alteration is located in exon 3 (coding exon 3) of the FOSL2 gene. This alteration results from a G to A substitution at nucleotide position 398, causing the arginine (R) at amino acid position 133 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
.;T;T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D
M_CAP
Uncertain
D
MetaRNN
Uncertain
D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
.;M;.
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;N;D
REVEL
Uncertain
Sift
Benign
T;T;D
Sift4G
Uncertain
D;D;D
Polyphen
1.0
.;D;.
Vest4
MutPred
0.49
.;Gain of ubiquitination at R133 (P = 0.0539);.;
MVP
MPC
3.2
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at